We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial (International presentation)
Section 19A approved medicine
(Approval lapsed) IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial (International presentation)
Section 19A approval holder
Sanofi-Aventis Australia Pty Ltd ABN 31 008 558 807
Phone
1800 818 806
Approved until
Status
Expired
Medicines in short supply/unavailable
IMOJEV japanese encephalitis vaccine (live, attenuated) powder for injection vial plus diluent vial AUST R: 162215
Indication(s)
Indicated for prophylaxis of Japanese encephalitis caused by the Japanese encephalitis virus, in individuals from 9 months of age and over.
Images
